Human Immunology ELISA Kits 12
Human VS (Versican/PG-M) ELISA Kit (HUES02300)
- SKU:
- HUES02300
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- P13611
- Sensitivity:
- 0.19ng/mL
- Range:
- 0.31-20ng/mL
- ELISA Type:
- Sandwich
- Synonyms:
- CSPG2, VCAN, ERVR, PG-M, WGN, WGN1, Chondroitin Sulfate Proteoglycan 2, Versican Proteoglycan
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection Method: | Colormetric |
Detection Range: | 0.31-20 ng/mL |
Sensitivity: | 0.19 ng/mL |
Sample Volume Required Per Well: | 100µL |
Sample Type: | Serum, plasma and other biological fluids |
Specificity: | This kit recognizes Human VS in samples. No significant cross-reactivity or interference between Human VS and analogues was observed. |
This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human VS. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human VS and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human VS, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by adding Stop Solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human VS. The concentration of Human VS in samples can be calculated by comparing the OD of the samples to the standard curve.
UniProt Protein Function: | CSPG2: May play a role in intercellular signaling and in connecting cells with the extracellular matrix. May take part in the regulation of cell motility, growth and differentiation. Binds hyaluronic acid. Defects in VCAN are the cause of Wagner syndrome type 1 (WGN1). WGN is a dominantly inherited vitreoretinopathy characterized by an optically empty vitreous cavity with fibrillary condensations and a preretinal avascular membrane. Other optical features include progressive chorioretinal atrophy, perivascular sheating, subcapsular cataract and myopia. Systemic manifestations are absent in WGN. Belongs to the aggrecan/versican proteoglycan family. 5 isoforms of the human protein are produced by alternative splicing. |
UniProt Protein Details: | Protein type:Cell adhesion; Motility/polarity/chemotaxis; Secreted; Secreted, signal peptide Chromosomal Location of Human Ortholog: 5q14. 3 Cellular Component: extracellular matrix; proteinaceous extracellular matrix; extracellular space; lysosomal lumen; intracellular membrane-bound organelle; membrane; Golgi lumen; extracellular region Molecular Function:protein binding; glycosaminoglycan binding; extracellular matrix structural constituent; hyaluronic acid binding; calcium ion binding; carbohydrate binding Biological Process: extracellular matrix organization and biogenesis; central nervous system development; chondroitin sulfate biosynthetic process; glycosaminoglycan metabolic process; multicellular organismal development; heart development; cell recognition; pathogenesis; glial cell migration; dermatan sulfate biosynthetic process; chondroitin sulfate metabolic process; osteoblast differentiation; chondroitin sulfate catabolic process; carbohydrate metabolic process; cell adhesion; skeletal development Disease: Wagner Vitreoretinopathy |
NCBI Summary: | This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009] |
UniProt Code: | P13611 |
NCBI GenInfo Identifier: | 21361116 |
NCBI Gene ID: | 1462 |
NCBI Accession: | NP_004376. 2 |
UniProt Secondary Accession: | P13611,P20754, Q13010, Q13189, Q15123, Q9UCL9, Q9UNW5 |
UniProt Related Accession: | P13611 |
Molecular Weight: | 369,688 Da |
NCBI Full Name: | versican core protein isoform 1 |
NCBI Synonym Full Names: | versican |
NCBI Official Symbol: | VCAN |
NCBI Official Synonym Symbols: | WGN; ERVR; GHAP; PG-M; WGN1; CSPG2 |
NCBI Protein Information: | versican core protein |
UniProt Protein Name: | Versican core protein |
UniProt Synonym Protein Names: | Chondroitin sulfate proteoglycan core protein 2; Chondroitin sulfate proteoglycan 2; Glial hyaluronate-binding protein; GHAP; Large fibroblast proteoglycan; PG-M |
UniProt Gene Name: | VCAN |
UniProt Entry Name: | CSPG2_HUMAN |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (ng/mL) | O.D | Average | Corrected |
20 | 2.182 2.232 | 2.207 | 2.147 |
10 | 1.444 1.492 | 1.468 | 1.408 |
5 | 0.848 0.81 | 0.829 | 0.769 |
2.5 | 0.374 0.39 | 0.382 | 0.322 |
1.25 | 0.221 0.219 | 0.22 | 0.16 |
0.63 | 0.156 0.15 | 0.153 | 0.093 |
0.31 | 0.098 0.118 | 0.108 | 0.048 |
0 | 0.053 0.067 | 0.06 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human VS were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human VS were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.92 | 2.97 | 8.70 | 0.87 | 3.16 | 9.15 |
Standard deviation | 0.05 | 0.13 | 0.39 | 0.06 | 0.17 | 0.38 |
C V (%) | 5.43 | 4.38 | 4.48 | 6.90 | 5.38 | 4.15 |
Recovery
The recovery of Human VS spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 85-98 | 92 |
EDTA plasma (n=5) | 92-104 | 98 |
Cell culture media (n=5) | 88-101 | 94 |
Linearity
Samples were spiked with high concentrations of Human VS and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 90-102 | 87-104 | 90-103 |
Average (%) | 95 | 95 | 95 | |
1:4 | Range (%) | 91-106 | 86-100 | 84-97 |
Average (%) | 97 | 92 | 89 | |
1:8 | Range (%) | 91-103 | 87-100 | 87-99 |
Average (%) | 97 | 92 | 92 | |
1:16 | Range (%) | 90-105 | 82-93 | 88-100 |
Average (%) | 97 | 88 | 95 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
Stop Solution | 1 vial, 10 mL | 4°C |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100 µL of standard solutions into the standard wells.
- Add 100 µL of Sample / Standard dilution buffer into the control (zero) well.
- Add 100 µL of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37 °C.
- Aspirate the liquid from each well, do not wash. Immediately add 100 µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37 °C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 90 µL of Substrate Reagent to each well. Cover with a new plate seal and incubate forapproximately 15 min at 37 °C. Protect the plate from light. Note: the reaction time can beshortened or extended according to the actual color change, but not by more than 30min.
- Add 50 µL of Stop Solution to each well. Note: Adding the stop solution should be done inthe same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm.